296 related articles for article (PubMed ID: 27315562)
21. Payment of USA physicians for dialysis care.
Kliger AS; Finkelstein FO
Perit Dial Int; 2004; 24(6):518-20. PubMed ID: 15559477
[No Abstract] [Full Text] [Related]
22. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
23. Medicare programs: changes to the end-stage renal disease prospective payment system transition budget-neutrality adjustment. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2011 Apr; 76(66):18930-4. PubMed ID: 21491804
[TBL] [Abstract][Full Text] [Related]
24. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
Anantharaman P; Moss AH
Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
[TBL] [Abstract][Full Text] [Related]
25. Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2012 Nov; 77(218):67450-531. PubMed ID: 23139948
[TBL] [Abstract][Full Text] [Related]
26. The 2011 ESRD prospective payment system: welcome to the bundle.
Weiner DE
Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
[No Abstract] [Full Text] [Related]
27. Physician reimbursement for outpatient dialysis care: Past, present, and future.
Anumudu SJ; Erickson KF
Semin Dial; 2020 Jan; 33(1):68-74. PubMed ID: 31944418
[TBL] [Abstract][Full Text] [Related]
28. The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.
Bhat P; Bhat JG
Am J Kidney Dis; 2011 Apr; 57(4):556-8. PubMed ID: 21316132
[No Abstract] [Full Text] [Related]
29. Effects of physician payment reform on provision of home dialysis.
Erickson KF; Winkelmayer WC; Chertow GM; Bhattacharya J
Am J Manag Care; 2016 Jun; 22(6):e215-23. PubMed ID: 27355909
[TBL] [Abstract][Full Text] [Related]
30. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
[TBL] [Abstract][Full Text] [Related]
31. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
Nissenson AR; Mayne TJ; Krishnan M
Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
[No Abstract] [Full Text] [Related]
32. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
Lacson E; Hakim RM
Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
[No Abstract] [Full Text] [Related]
33. Medicare's payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs.
Swaminathan S; Mor V; Mehrotra R; Trivedi A
Health Aff (Millwood); 2012 Sep; 31(9):2051-8. PubMed ID: 22949455
[TBL] [Abstract][Full Text] [Related]
34. Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.
Wish D; Johnson D; Wish J
Clin J Am Soc Nephrol; 2014 Dec; 9(12):2195-202. PubMed ID: 25189926
[TBL] [Abstract][Full Text] [Related]
35. Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.
Swaminathan S; Mor V; Mehrotra R; Trivedi AN
Health Serv Res; 2015 Jun; 50(3):790-808. PubMed ID: 25355431
[TBL] [Abstract][Full Text] [Related]
36. Bundling and its potential impact on dialysis service providers.
Sullivan J
Nephrol News Issues; 2008 Oct; 22(11):12, 14, 16-7. PubMed ID: 19009855
[No Abstract] [Full Text] [Related]
37. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
[TBL] [Abstract][Full Text] [Related]
38. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
39. The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.
Johnson DS; Meyer KB; Johnson HK
Am J Kidney Dis; 2011 Apr; 57(4):553-5. PubMed ID: 21333427
[No Abstract] [Full Text] [Related]
40. Special treatment--the story of Medicare's ESRD entitlement.
Rettig RA
N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
